{"drugs":["Plasma Protein Fraction","Plasmanate"],"mono":{"0":{"id":"470300-s-0","title":"Generic Names","mono":"Plasma Protein Fraction"},"1":{"id":"470300-s-1","title":"Dosing and Indications","sub":{"0":{"id":"470300-s-1-4","title":"Adult Dosing","mono":"<b>Hypovolemia:<\/b> 12.5-25 g (250-500 mL) IV, repeat as needed"},"1":{"id":"470300-s-1-5","title":"Pediatric Dosing","mono":"Safety and efficacy in children not established"},"3":{"id":"470300-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Hypovolemia<br\/>"}}},"3":{"id":"470300-s-3","title":"Contraindications\/Warnings","sub":[{"id":"470300-s-3-9","title":"Contraindications","mono":"<ul><li>cardiopulmonary bypass<\/li><li>congestive heart failure<\/li><li>hypersensitivity to albumin<\/li><li>hypoproteinemia associated with chronic nephrosis, chronic cirrhosis, malabsorption, protein-losing enteropathies, pancreatic insufficiency, and undernutrition<\/li><li>increased or normal intravascular volume<\/li><li>renal insufficiency<\/li><li>severe anemia<\/li><\/ul>"},{"id":"470300-s-3-10","title":"Precautions","mono":"<ul><li>hepatic dysfunction<\/li><li>plasma protein fraction is made from human plasma and products made from human plasma may contain infectious agents (hepatitis C)<\/li><\/ul>"},{"id":"470300-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"470300-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"470300-s-5","title":"Adverse Effects","mono":"<b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Hypotension<\/li><li><b>Immunologic:<\/b>Hypersensitivity reaction, Shaking, chills, urticaria<\/li><\/ul>"},"6":{"id":"470300-s-6","title":"Drug Name Info","sub":{"0":{"id":"470300-s-6-17","title":"US Trade Names","mono":"Plasmanate<br\/>"},"2":{"id":"470300-s-6-19","title":"Class","mono":"Volume Expander<br\/>"},"3":{"id":"470300-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"470300-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"470300-s-7","title":"Mechanism Of Action","mono":"Plasma protein fraction is used as a human plasma replacement. It increases blood volume and provides protein for osmotic effect.<br\/>"},"9":{"id":"470300-s-9","title":"Administration","mono":"<b>Intravenous<\/b><br\/><ul><li>use only 16 gauge needles or dispensing pins with 20 mL or larger vial sizes; insert needles or dispensing pins only within the stopper area (marked by the raised ring)<\/li><li>administer some distance from any site of infection or trauma<\/li><li>rate should be adjusted according to clinical response and changes in blood pressure; risk of hypotension with rapid infusion (greater than 10 mL\/min) 2156370<\/li><li>compatible with most common carbohydrate and electrolyte solutions<\/li><li>solution that has been frozen should not be used<\/li><\/ul>"},"10":{"id":"470300-s-10","title":"Monitoring","mono":"blood pressure; especially with rapid infusion <br\/>"},"11":{"id":"470300-s-11","title":"How Supplied","mono":"<b>Plasmanate<\/b><br\/>Intravenous Solution: 5 %<br\/>"},"13":{"id":"470300-s-13","title":"Clinical Teaching","mono":"Despite screening and testing, human plasma products carry a remote risk of transmitting infectious agents. Risks and benefits should be discussed with patient by healthcare professional.<br\/>"}}}